Connaughton Bernadette sold HALO
September 2, 2025 · Form 4 insider transaction
Connaughton Bernadette sold 100 shares of Halozyme Therapeutics, Inc. at $71.71 per share, a transaction worth $7.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
100
Price
$71.71
Total value
$7.2K
InsiderConnaughton Bernadette
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 2, 2025
Filing dateSeptember 2, 2025
Shares owned after50,852
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on May 29, 2025 in accordance with Rule 10b5-1.